Thyroid cancer surgery during the coronavirus disease 2019 pandemic: perioperative management and oncological and anatomical considerations.
Future Oncol
; 17(32): 4389-4395, 2021 Nov.
Article
in English
| MEDLINE | ID: covidwho-1372054
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has changed many aspects of our everyday lives and medical practice, including oncology treatment; thyroid cancer surgery is not an exception. The reported number of fine-needle aspirations performed during the first semester of 2020 was significantly reduced. Poorly differentiated, medullary and anaplastic thyroid tumors are considered important indications for immediate surgical intervention. By contrast, most well-differentiated carcinomas present slow growth, and thus surgery can be deferred for a short period of time during which patients are under active surveillance. Thyroid surgeries have decreased during the COVID-19 pandemic. Furthermore, prior to any intervention, negative COVID-19 status - with the use of a nasopharyngeal swab and reverse transcription PCR assay as the gold standard and chest CT scan as a complementary modality in some cases - must be confirmed to achieve a COVID-free pathway. Thorough preoperative assessment regarding both oncological and anatomical aspects should be performed to identify optimal timing for safe management.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Primary Prevention
/
Thyroidectomy
/
Thyroid Neoplasms
/
Triage
/
Time-to-Treatment
Type of study:
Diagnostic study
/
Observational study
Limits:
Humans
Language:
English
Journal:
Future Oncol
Year:
2021
Document Type:
Article
Affiliation country:
Fon-2021-0585
Similar
MEDLINE
...
LILACS
LIS